Comparison

Elimusertib (hydrochloride) European Partner

Item no. HY-101566A-5mg
Manufacturer MedChem Express
Amount 5 mg
Quantity options 100 mg 10 mM/1 mL 10 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.85
Citations [1]Ulrich T. Luecking, et al. Abstract 983: Identification of potent, highly selective and orally available ATR inhibitor BAY 1895344 with favorable PK properties and promising efficacy in monotherapy and combination in preclinical tumor models. Cancer Research. July 2017 Volume 77, Issue 13 Supplement.|[2]Antje Margret Wengner, et al. Abstract 836: ATR inhibitor BAY 1895344 shows potent anti-tumor efficacy in monotherapy and strong combination potential with the targeted alpha therapy Radium-223 dichloride in preclinical tumor models. Cancer Research. July 2017 Volume 77, Issue 13 Supplement|[3]Ulrich Lücking, et al. Damage Incorporated: Discovery of the Potent, Highly Selective, Orally Available ATR Inhibitor BAY 1895344 with Favorable Pharmacokinetic Properties and Promising Efficacy in Monotherapy and in Combination Treatments in Preclinical Tumor Models. J Med Chem. 2020 Jul 9;63(13):7293-7325.
Cancer Res. 2022 Jan 12;canres.1707.2021.|Biochem Pharmacol. 2023 Mar 14;115494.|Exp Mol Med. 2025 Jan 6.|J Med Chem. 2024 Feb 22;67(4):2349-2368.|Mol Cell Biol. 2025 Feb 2:1-17.|Nat Commun. 2024 Oct 24;15(1):9195.|Research Square Preprint. 2023 Jun 9.|Research Square Preprint. 2023 May 17.|Research Square Preprint. 2023 Nov 20.
Smiles CN1N=CC=C1C2=C(C=CN=C3C4=CC=NN4)C3=NC(N5[C@H](C)COCC5)=C2.[H]Cl
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BAY 1895344 (hydrochloride)
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-Kinase/protease
Manufacturer - Targets
ATM/ATR
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Molecular Weight
411.89
Product Description
Elimusertib (BAY 1895344) hydrochloride is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. Elimusertib hydrochloride has anti-tumor activity[1][2]. Elimusertib hydrochloride can be used for the research of solid tumors and lymphomas[3].
Manufacturer - Research Area
Cancer
Solubility
DMSO: 50 mg/mL (ultrasonic)|H2O: 50 mg/mL (ultrasonic)
Manufacturer - Pathway
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Isoform
ATR
Clinical information
Phase 2

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close